Fitzpatrick Alexander A
- SEC CIK
- 0001398595
In the past year, 1 open-market sale filing worth $33.5K and no purchases.
Current role at each company
- SPRY ARS Pharmaceuticals, Inc.Chief Legal Officeras of Jun 12, 2026
- EVFM Evofem Biosciences, Inc.General Counsel and Secretaryas of Feb 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $33.5K
- 1 filing
- Net
- −$33.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Fitzpatrick Alexander A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SPRY ARS Pharmaceuticals, Inc.
Chief Legal Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 (view filing) | Sep 28-29 | 4 days | Fitzpatrick Alexander AChief Legal Officer | PPurchase | +86.3K | $3.71 | +$319.7K | +2,905.3%89.2K after | 2 lots |
| May 22, 2025 (view filing) | May 20 | 2 days | Fitzpatrick Alexander AChief Legal Officer | SSale | −103.0K | $14.10 | −$1.45M | −53.5%89.6K after | |
| Jun 12, 2026 (view filing) | Jun 12 | Same day | Fitzpatrick Alexander AChief Legal Officer | SSale | −3.35K | $10.00 | −$33.5K | −3.6%90.9K after | 10b5-1 |
EVFM Evofem Biosciences, Inc.
General Counsel and Secretary1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 (view filing)4:20 PM ET | Dec 20 | Same day | Fitzpatrick Alexander AGeneral Counsel and Secretary | PPurchase | +25.0K | $0.389 | +$9.72K | +8.0%336.4K after |